The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence

Eoghan M McCarthy; Emily Sutton; Stephanie Nesbit; Ben Parker; David Jayne; Bridget Griffiths; David A Isenberg; Anisur Rahman; Caroline Gordon; David P D'Cruz; Benjamin Rhodes; Peter Lanyon; Edward M Vital; Chee-Seng Yee; Christopher J Edwards; Lee-Suan Teh; Mohammed Akil; Neil J McHugh; Asad Zoma; Ian N Bruce; British Isles Lupus Assessment Group Biologics Register

doi:10.1093/rheumatology/kex044

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence

Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, Ben Parker, David Jayne, Bridget Griffiths, David A Isenberg, Anisur Rahman, Caroline Gordon, David P D'Cruz, Benjamin Rhodes, Peter Lanyon, Edward M Vital, Chee-Seng Yee, Christopher J Edwards, Lee-Suan Teh, Mohammed Akil, Neil J McHugh, Asad Zoma, Ian N BruceBritish Isles Lupus Assessment Group Biologics Register

Research output: Contribution to journal › Letter › peer-review

3 Citations (SciVal)

Original language	English
Pages (from-to)	1041-1043
Number of pages	3
Journal	Rheumatology
Volume	56
Issue number	6
Early online date	18 Apr 2017
DOIs	https://doi.org/10.1093/rheumatology/kex044
Publication status	Published - 1 Jun 2017

Keywords

Journal Article

Access to Document

10.1093/rheumatology/kex044

Cite this

McCarthy, E. M., Sutton, E., Nesbit, S., Parker, B., Jayne, D., Griffiths, B., Isenberg, D. A., Rahman, A., Gordon, C., D'Cruz, D. P., Rhodes, B., Lanyon, P., Vital, E. M., Yee, C-S., Edwards, C. J., Teh, L-S., Akil, M., McHugh, N. J., Zoma, A., ... British Isles Lupus Assessment Group Biologics Register (2017). The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence. Rheumatology, 56(6), 1041-1043. https://doi.org/10.1093/rheumatology/kex044

McCarthy, EM, Sutton, E, Nesbit, S, Parker, B, Jayne, D, Griffiths, B, Isenberg, DA, Rahman, A, Gordon, C, D'Cruz, DP, Rhodes, B, Lanyon, P, Vital, EM, Yee, C-S, Edwards, CJ, Teh, L-S, Akil, M, McHugh, NJ, Zoma, A, Bruce, IN & British Isles Lupus Assessment Group Biologics Register 2017, 'The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence', Rheumatology, vol. 56, no. 6, pp. 1041-1043. https://doi.org/10.1093/rheumatology/kex044

@article{b1e063602be54ef3ac48ac876f1fcaa4,

title = "The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence",

keywords = "Journal Article",

author = "McCarthy, {Eoghan M} and Emily Sutton and Stephanie Nesbit and Ben Parker and David Jayne and Bridget Griffiths and Isenberg, {David A} and Anisur Rahman and Caroline Gordon and D'Cruz, {David P} and Benjamin Rhodes and Peter Lanyon and Vital, {Edward M} and Chee-Seng Yee and Edwards, {Christopher J} and Lee-Suan Teh and Mohammed Akil and McHugh, {Neil J} and Asad Zoma and Bruce, {Ian N} and {British Isles Lupus Assessment Group Biologics Register}",

year = "2017",

month = jun,

day = "1",

doi = "10.1093/rheumatology/kex044",

language = "English",

volume = "56",

pages = "1041--1043",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence

AU - McCarthy, Eoghan M

AU - Sutton, Emily

AU - Nesbit, Stephanie

AU - Parker, Ben

AU - Jayne, David

AU - Griffiths, Bridget

AU - Isenberg, David A

AU - Rahman, Anisur

AU - Gordon, Caroline

AU - D'Cruz, David P

AU - Rhodes, Benjamin

AU - Lanyon, Peter

AU - Vital, Edward M

AU - Yee, Chee-Seng

AU - Edwards, Christopher J

AU - Teh, Lee-Suan

AU - Akil, Mohammed

AU - McHugh, Neil J

AU - Zoma, Asad

AU - Bruce, Ian N

AU - British Isles Lupus Assessment Group Biologics Register

PY - 2017/6/1

Y1 - 2017/6/1

KW - Journal Article

UR - https://doi.org/10.1093/rheumatology/kex044

U2 - 10.1093/rheumatology/kex044

DO - 10.1093/rheumatology/kex044

M3 - Letter

C2 - 28431104

SN - 1462-0324

VL - 56

SP - 1041

EP - 1043

JO - Rheumatology

JF - Rheumatology

IS - 6

ER -

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence

Keywords

Access to Document

Other files and links

Cite this